AbbVie 2012 Annual Report Download - page 107

Download and view the complete annual report

Please find page 107 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 200

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200

EXHIBIT INDEX
ABBVIE INC.
ANNUAL REPORT
FORM 10-K
2012
Exhibits 32.1 and 32.2 are furnished herewith and should not be deemed to be ‘‘filed under the
Securities Exchange Act of 1934.’’
Exhibit
Number Exhibit Description
2.1 *Separation and Distribution Agreement by and between Abbott Laboratories and
AbbVie Inc. (incorporated by reference to Exhibit 2.1 of Amendment No. 6 to the Company’s
Registration Statement on Form 10 filed on November 30, 2012).
3.1 *Amended and Restated Certificate of Incorporation of AbbVie Inc. (incorporated by
reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on January 2,
2013).
3.2 *Amended and Restated By-Laws of AbbVie Inc. (incorporated by reference to Exhibit 3.2 of
the Company’s Current Report on Form 8-K filed on January 2, 2013).
4.1 *Indenture dated as of November 8, 2012 between AbbVie Inc. and U.S. Bank National
Association (incorporated by reference to Exhibit 4.1 of Amendment No. 5 to the Company’s
Registration Statement on Form 10 filed on November 16, 2012).
4.2 *Supplemental Indenture No. 1 dated as of November 8, 2012 among AbbVie Inc. and U.S.
Bank National Association (incorporated by reference to Exhibit 4.2 of Amendment No. 5 to
the Company’s Registration Statement on Form 10 filed on November 16, 2012).
4.3 *Registration Rights Agreement dated November 8, 2012 by and among AbbVie Inc., Abbott
Laboratories, Morgan Stanley & Co. LLC, Barclays Capital Inc., J.P. Morgan Securities LLC
and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to
Exhibit 4.3 of Amendment No. 5 to the Company’s Registration Statement on Form 10 filed
on November 16, 2012).
10.1 *U.S. Transition Services Agreement by and between Abbott Laboratories and AbbVie Inc.
(incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K
filed on January 2, 2013).
10.2 *Ex-U.S. Transition Services Agreement by and between Abbott Laboratories and AbbVie Inc.
(incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K
filed on January 2, 2013).
10.3 *Tax Sharing Agreement by and between Abbott Laboratories and AbbVie Inc. (incorporated
by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed on
January 2, 2013).
10.4 *Special Products Master Agreement by and between Abbott Laboratories and AbbVie Inc.
(incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K
filed on January 2, 2013).
10.5 *Employee Matters Agreement by and between Abbott Laboratories and AbbVie Inc.
(incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K
filed on January 2, 2013).
101